Skip to main content
. 2022 Aug 8;10(10):2667–2676.e10. doi: 10.1016/j.jaip.2022.07.027

Table I.

Baseline characteristics

Demographic characteristic Immediate hypersensitivity reactions
Immunization stress-related responses
Cases 1 (N = 306) Controls 1 (N = 1224) P value Cases 2 (N = 2478) Controls 2 (N = 9912) P value
Age (y)
 >65 108 (35) 467 (38) .817 430 (20) 2344 (26) <.001
 51-65 69 (23) 258 (21) 361 (13) 1913 (18)
 36-50 68 (22) 264 (22) 620 (26) 2815 (29)
 ≤35 61 (20) 235 (19) 1067 (41) 2840 (27)
Sex
 Male 63 (21) 692 (57) <.001 827 (33) 5475 (55) <.001
 Female 243 (79) 532 (44) 1651 (67) 4437 (45)
Comorbidities
 Hypertension 40 (13) 156 (13) .848 163 (7) 899 (9) <.001
 Dyslipidemia 17 (6) 58 (5) .552 89 (4) 406 (4) .303
 Diabetes 12 (4) 59 (5) .647 55 (2) 351 (4) .002
 Cardiovascular diseases 5 (2) 40 (3) .182 57 (2) 197 (2) .284
 Asthma 24 (8) 17 (1) <.001 96 (4) 123 (1) <.001
 Atopic dermatitis 5 (2) 3 (0) .010 21 (1) 36 (0) .002
 Thyroid diseases 15 (5) 13 (1) <.001 50 (2) 89 (1) <.001
 Malignancy 6 (2) 21 (2) .807 26 (1) 90 (1) .476
 Mental disorders 7 (2) 20 (2) .463 113 (5) 127 (1) <.001
 Missing data of comorbidities 4 (1) 0 33 (1) 0
History
 Allergic episodes for drugs 86 (28) 41 (3) <.001 320 (13) 303 (3) <.001
 Allergic episodes for foods 80 (26) 33 (3) <.001 308 (12) 327 (3) <.001
 Vasovagal episode 9 (3) 10 (1) .006 246 (10) 136 (1) <.001
 Missing data of histories 6 (2) 0 45 (2) 10 (0)
No. of vaccine received
 First 207 (68) 828 (68) 1.000 1844 (74) 7376 (74) 1.000
 Second 99 (32) 396 (32) 634 (26) 2536 (26)
Period
 May 24-June 23 98 (32) 392 (32) 1.000 486 (20) 1944 (20) 1.000
 June 24-July 23 58 (19) 232 (19) 323 (13) 1292 (13)
 July 24-August 23 89 (29) 356 (29) 1071 (43) 4284 (43)
 August 24-September 24 61 (19) 244 (20) 598 (24) 2392 (24)

Data are presented as n (%).

P value showed a comparison between cases 1 and control 1.

P value showed a comparison between cases 2 and control 2.